These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21585620)

  • 21. Expression of caveolin-1 in mucoepidermoid carcinoma of the salivary glands: correlation with vascular endothelial growth factor, microvessel density, and clinical outcome.
    Shi L; Chen XM; Wang L; Zhang L; Chen Z
    Cancer; 2007 Apr; 109(8):1523-31. PubMed ID: 17342767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urokinase type plasminogen activator receptor is a novel prognostic factor in breast cancer.
    Kim SJ; Shiba E; Taguchi T; Watanabe T; Tanji Y; Kimoto Y; Izukura M; Takai SI
    Anticancer Res; 1997; 17(2B):1373-8. PubMed ID: 9137501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.
    Denkert C; Winzer KJ; Müller BM; Weichert W; Pest S; Köbel M; Kristiansen G; Reles A; Siegert A; Guski H; Hauptmann S
    Cancer; 2003 Jun; 97(12):2978-87. PubMed ID: 12784332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers.
    Witkiewicz AK; Dasgupta A; Sammons S; Er O; Potoczek MB; Guiles F; Sotgia F; Brody JR; Mitchell EP; Lisanti MP
    Cancer Biol Ther; 2010 Jul; 10(2):135-43. PubMed ID: 20431349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of caveolin-1 expression in carcinoma-associated fibroblasts of invasive micropapillary carcinoma of the breast predicts poor patient outcome.
    Ren M; Liu F; Zhu Y; Li Y; Lang R; Fan Y; Gu F; Zhang X; Fu L
    Virchows Arch; 2014 Sep; 465(3):291-8. PubMed ID: 24980157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome.
    El-Gendi SM; Mostafa MF; El-Gendi AM
    Pathol Oncol Res; 2012 Apr; 18(2):459-69. PubMed ID: 22057638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of stromal caveolin-1 expression: a novel tumor microenvironment biomarker that can predict poor clinical outcomes for pancreatic cancer.
    Shan T; Lu H; Ji H; Li Y; Guo J; Chen X; Wu T
    PLoS One; 2014; 9(6):e97239. PubMed ID: 24949874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular profiling of a lethal tumor microenvironment, as defined by stromal caveolin-1 status in breast cancers.
    Witkiewicz AK; Kline J; Queenan M; Brody JR; Tsirigos A; Bilal E; Pavlides S; Ertel A; Sotgia F; Lisanti MP
    Cell Cycle; 2011 Jun; 10(11):1794-809. PubMed ID: 21521946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined caveolin-1 and epidermal growth factor receptor expression as a prognostic marker for breast cancer.
    Liang YN; Liu Y; Wang L; Yao G; Li X; Meng X; Wang F; Li M; Tong D; Geng J
    Oncol Lett; 2018 Jun; 15(6):9271-9282. PubMed ID: 29805656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diversity in the expression profile of caveolin II transcripts, considering its new transcript in breast cancer.
    Ariana M; Arabi N; Pornour M; Vaseghi H; Ganji SM; Alivand MR; Salari M; Akbari ME
    J Cell Biochem; 2018 Feb; 119(2):2168-2178. PubMed ID: 28857238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes.
    Senetta R; Miracco C; Lanzafame S; Chiusa L; Caltabiano R; Galia A; Stella G; Cassoni P
    Neuro Oncol; 2011 Feb; 13(2):176-83. PubMed ID: 21059755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts.
    Bonuccelli G; Whitaker-Menezes D; Castello-Cros R; Pavlides S; Pestell RG; Fatatis A; Witkiewicz AK; Vander Heiden MG; Migneco G; Chiavarina B; Frank PG; Capozza F; Flomenberg N; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Cell Cycle; 2010 May; 9(10):1960-71. PubMed ID: 20495363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts.
    Sotgia F; Del Galdo F; Casimiro MC; Bonuccelli G; Mercier I; Whitaker-Menezes D; Daumer KM; Zhou J; Wang C; Katiyar S; Xu H; Bosco E; Quong AA; Aronow B; Witkiewicz AK; Minetti C; Frank PG; Jimenez SA; Knudsen ES; Pestell RG; Lisanti MP
    Am J Pathol; 2009 Mar; 174(3):746-61. PubMed ID: 19234134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of stromal caveolin-1 expression in malignant melanoma metastases predicts poor survival.
    Wu KN; Queenan M; Brody JR; Potoczek M; Sotgia F; Lisanti MP; Witkiewicz AK
    Cell Cycle; 2011 Dec; 10(24):4250-5. PubMed ID: 22134245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of caveolin-1 in cancer-associated fibroblasts predicts good outcome in breast cancer.
    Shan-Wei W; Kan-Lun X; Shu-Qin R; Li-Li Z; Li-Rong C
    Breast Care (Basel); 2012 Dec; 7(6):477-83. PubMed ID: 24715830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of caveolin-1 expression in gastric cancer: a meta-analysis.
    Ye Y; Miao SH; Lu RZ; Zhou JW
    Asian Pac J Cancer Prev; 2014; 15(19):8367-70. PubMed ID: 25339030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Towards a new "stromal-based" classification system for human breast cancer prognosis and therapy.
    Witkiewicz AK; Casimiro MC; Dasgupta A; Mercier I; Wang C; Bonuccelli G; Jasmin JF; Frank PG; Pestell RG; Kleer CG; Sotgia F; Lisanti MP
    Cell Cycle; 2009 Jun; 8(11):1654-8. PubMed ID: 19448435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caveolin-1 is Markedly Downregulated in Patients with Early-Stage Colorectal Cancer.
    Torrejón B; Cristóbal I; Rojo F; García-Foncillas J
    World J Surg; 2017 Oct; 41(10):2625-2630. PubMed ID: 28560511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantum-dots based simultaneous detection of multiple biomarkers of tumor stromal features to predict clinical outcomes in gastric cancer.
    Peng CW; Tian Q; Yang GF; Fang M; Zhang ZL; Peng J; Li Y; Pang DW
    Biomaterials; 2012 Aug; 33(23):5742-52. PubMed ID: 22594973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stromal markers AKR1C1 and AKR1C2 are prognostic factors in primary human breast cancer.
    Wenners A; Hartmann F; Jochens A; Roemer AM; Alkatout I; Klapper W; van Mackelenbergh M; Mundhenke C; Jonat W; Bauer M
    Int J Clin Oncol; 2016 Jun; 21(3):548-56. PubMed ID: 26573806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.